Secondary Metabolites with New Medicinal Functions from Marine Organisms

Advances in Food and Nutrition Research

Volumn 65, Issue , 2012, Pages 185-193

  Ohno, Osamu ^a   Suenaga, Kiyotake ^a   Uemura, Daisuke ^b  

^a KEIO UNIVERSITY   (Japan)

^b KANAGAWA UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Halichlorine; Marine organisms; Secondary metabolites

Indexed keywords

EID: 84857221560     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-416003-3.00011-1     Document Type: Chapter

References (40)

1. Allen S., Khan S., Al-Mohanna F., Batten P., Yacoub M. Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J. Clin. Invest. 1998, 101:1064-1075.
2. Ariga A., Namekawa J., Matsumoto N., Inoue J., Umezawa K. Inhibition of tumor necrosis factor-α-induced nuclear translocation and activation of NF-κB by dehydroxymethylepoxyquinomicin. J. Biol. Chem. 2002, 277:24625-24630.
3. Arimoto H., Hayakawa I., Kuramoto M., Uemura D. Absolute stereochemistry of halichlorine; a potent inhibitor of VCAM-1 induction. Tetrahedron Lett. 1998, 39:861-862.
4. Chiba T., Kondo Y., Shinozaki S., Kaneko E., Ishigami A., Maruyama N., Umezawa K., Shimokado K. A selective NFκB inhibitor, DHMEQ, reduced atherosclerosis in ApoE-deficient mice. J. Atheroscler. Thromb. 2006, 13:308-313.
5. Clive D.L.J., Yu M., Wang J., Yeh V.S.C., Kang S. Synthetic chemistry of halichlorine and the pinnaic acids. Chem. Rev. 2005, 105:4483-4514.
6. Cybulsky M.I., Gimbrone M.A. Endothelial expression of mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991, 251:788-791.
7. Diamond M.S., Staunton D.E., de Fougerolles A.R., Stacker S.A., Garcia-Aguilar J., Hibbs M.L., Springer T.A. ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J. Cell Biol. 1990, 111:3129-3139.
8. Dustin M.L., Rothlein R., Bhan A.K., Dinarello C.A., Springer T.A. Induction by IL-1 and interferon-γ: Tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 1986, 137:245-254.
9. Elices M.J., Osborn L., Takada Y., Crouse C., Luhowskyj S., Hemler M.E., Lobb R.R. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site. Cell 1990, 60:577-584.
10. Gerrity R.G., Naito H.K., Richardson M., Schwartz C.J. Dietary induced atherogenesis in swine. Am. J. Pathol. 1979, 95:775-785.
11. Glass C.K., Witztum J.L. Atherosclerosis: The road ahead. Cell 2001, 104:503-516.
12. Haraldsen G., Kvale D., Lien B., Farstad I.N., Brandtzaeg P. Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J. Immunol. 1996, 56:2558-2565.
13. Hirata Y., Uemura D. Halichondrins-Antitumor polyether macrolides from a marine sponge. Pure Appl. Chem. 1986, 58:701-707.
14. Huyck T.K., Gradishar W., Manuguid F., Kirkpatrick P. Eribulin mesylate. Nat. Rev. Drug Discov. 2011, 10:173-174.
15. Iademarco M.F., McQuillan J.J., Rosen G.D., Dean D.C. Characterization of the promoter for vascular cell adhesion molecule-1 (VCAM-1). J. Biol. Chem. 1992, 267:16323-16329.
16. Karaki H., Ozaki H., Hori M., Mitsui-Saito M., Amano K., Harada K., Miyamoto S., Nakazawa H., Won K.J., Sato K. Calcium movements, distribution, and functions in smooth muscle. Pharmacol. Rev. 1997, 49:157-230.
17. Karin M., Greten F.R. NF-κB: Linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005, 5:749-759.
18. Kock A.E., Halloran M.M., Haskell C.J., Sah M.R., Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519.
19. Kuramoto M., Chou T., Yamada K., Chiba T., Hayashi Y., Uemura D. Halichlorine, an inhibitor of VCAM-1 induction from the marine sponge Halichondria okadai Kadota. Tetrahedron Lett. 1996, 37:3867-3870.
20. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
21. Liu D., Acharya H.P., Yu M., Wang J., Yeh V.S., Kang S., Chiruta C., Jachak S.M., Clive D.L. Total synthesis of the marine alkaloid halichlorine: Development and use of a general route to chiral piperidines. J. Org. Chem. 2009, 74:7417-7428.
22. Marlin S.D., Springer T.A. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987, 51:813-819.
23. Ohno O., Ikeda Y., Sawa R., Igarashi M., Kinoshita N., Suzuki Y., Miyake K., Umezawa K. Isolation of heptadepsin, a novel bacterial cyclic depsipeptide that inhibits lipopolysaccharide activity. Chem. Biol. 2004, 11:1059-1070.
24. Ohno O., Shima Y., Ikeda Y., Sakurai K., Watanabe K., Kawai Y., Umezawa K. Inhibition of cellular adhesion in human umbilical vein endothelial cells by NF-κB inhibitor DHMEQ under flow. Oncol. Res. 2005, 15:189-197.
25. Raetz C.R., Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 2002, 71:635-700.
26. Rothlein R., Dustin M.L., Marlin S.D., Springer T.A. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J. Immunol. 1986, 137:1270-1274.
27. Sen R., Baltimore D. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 1986, 46:705-715.
28. Smith C.W. 3. Adhesion molecules and receptors. J. Allergy Clin. Immunol. 2008, 121:S375-S379.
29. van de Stolpe A., Caldenhoven E., Stade B.G., Koenderman L., Raaijmakers J.A., Johnson J.P., van der Saag P.T. 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor α-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J. Biol. Chem. 1994, 269:6185-6192.
30. Takahashi T., Ohno O., Ikeda Y., Sawa R., Homma Y., Igarashi M., Umezawa K. Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin. J. Antibiot. 2006, 59:35-43.
31. Towle M.J., Salvato K.A., Budrow J., Wels B.F., Kuznetsov G., Aalfs K.K., Welsh S., Zheng W., Seletsky B.M., Palme M.H., Habgood G.J., Singer L.A., et al. In vitro and in vivo anticancer activities of synthetic macrocyclic ketone analogues of halichondrin B. Cancer Res. 2001, 61:1013-1021.
32. Trauner D., Schwarz J.B., Danishefsky S.J. Total synthesis of (+)-halichlorine: An inhibitor of VCAM-1 expression. Angew. Chem. Int. Ed. Engl. 1999, 38:3542-3545.
33. 2+ channel inhibitor isolated from the marine sponge Halichondria okadai Kadota. Eur. J. Pharmacol. 2010, 628:128-131.
34. Tsubosaka Y., Murata T., Yamada K., Uemura D., Hori M., Ozaki H. Halichlorine reduces monocyte adhesion to endothelium through the suppression of nuclear factor-κB activation. J. Pharmacol. Sci. 2010, 113:208-213.
35. Uemura D. Bioorganic studies on marine natural products-Diverse chemical structures and bioactivities. Chem. Rec. 2006, 6:235-248.
36. Uemura D. Exploratory research on bioactive natural products with a focus on biological phenomena. Proc. Jpn. Acad. Ser. B Phys. Biol. Sci. 2010, 86:190-201.
37. Uemura D., Kita M., Arimoto H., Kitamura M. Recent aspects of chemical ecology: Natural toxins, coral communities, and symbiotic relationships. Pure Appl. Chem. 2009, 81:1093-1111.
38. Uemura D., Takahashi K., Yamamoto T., Katayama C., Tanaka J., Okumura Y., Hirata Y. Norhalichondrin A, an antitumor polyether macrolide from a marine sponge. J. Am. Chem. Soc. 1985, 107:4796-4798.
39. Wittig B.M., Kaulen H., Thees R., Schmitt C., Knolle P., Stock J., Meyer zum Buschenfelde K.H., Dippold W. Elevated serum E-selectin in patients with liver metastases of colorectal cancer. Eur. J. Cancer 1996, 32A:1215-1218.
40. Whelan J., Ghersa P., Hooft van Huijsduijnen R., Gray J., Chandra G., Talabot F., DeLamarter J.F. An NFκB-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res. 1991, 19:2645-2653.